IMAUD: Your Gateway to Mastering Market Access
Master market access with the most practical, expert-led online market access course for healthcare, pharmaceutical, and life sciences professionals. Join the waitlist and get free lesson!
What is IMAUD?
IMAUD is a comprehensive online market access course tailored for healthcare, pharmaceutical, and life sciences professionals. You will gain essential skills to design effective market access strategies, navigate pricing and reimbursement in healthcare, and position products for success in competitive markets.
If you’re asking how to become a market access specialist, IMAUD provides the tools, frameworks, and expert mentorship you need. Whether you need pharmaceutical market access training or seek to deepen your expertise, this course equips you to excel.
New in This Edition
🎯
Curated Content:
Focused training on market access
essentials,without the fluff.
⏱️
Bite-Sized Lessons:
Each lesson lasts just 15-25 minutes,
easy to fit into any schedule.
📱
On-Demand Access:
Learn anytime, anywhere,
with long access to all materials.
❓
Live Q&A Sessions
Deepen your understanding
by asking questions directly
to the course lecturers and explore
topics that interest you in more detail.
🛠️
Workshops
Gain practical insights
and network during exclusive live
sessions hosted by
top Market Access experts.
🤝
New Learning Platform:
Join a vibrant community
on the our platform featuring live chat,
discussion forums, and a rich library
of knowledge resources.
Program Structure
- 8-week program designed to fit into your schedule with just 25 minutes a day.
- Live expert sessions and interactive Q&A.
- Practical assignments with real-world case studies.
- Long access to content.
- Built-in buffer period to help you catch up if life gets in the way.
- Certificate of completion provided upon successful course participation.
Let's see how it works?
✅ Simple and intuitive student dashboard to manage your learning.
✅ Track your progress through modules and lessons.
✅ Only 25 minutes of video content per day — efficient and manageable.
✅ Access to an exclusive community of peers and professionals.
❌ No long video lectures to sit through.
❌ No bulky slide decks to struggle through alone.
❌ No wasted time — every minute is focused, purposeful, and practical.
❌ No overwhelming content — everything is broken down into actionable, easy-to-follow lessons
What Will Change When You Join This Online Market Access Course?
💎
You will master comprehensive market access strategy
and proven framework
🗓️
You will develop, validate, and execute a full market access plan.
🧠
You will build a compelling value story to optimize product access.
💊
You will anticipate future paradigm shifts in pharmaceutical market access
💸
You will learn to design and apply pricing research for strategic advantage.
📈
You will confidently navigate pricing and reimbursement in healthcare globally
💎
You will master comprehensive market access strategy
and proven framework
🗓️
You will develop, validate, and execute a full market access plan.
🧠
You will build a compelling value story to optimize product access.
💊
You will anticipate future paradigm shifts in pharmaceutical market access
💸
You will learn to design and apply pricing research for strategic advantage.
📈
You will confidently navigate pricing and reimbursement in healthcare globally
Who is This Program For?
- ✅ Market Access Professionals enhancing their expertise.
- ✅ Students in Medicine, Pharmacy, or Life Sciences looking to break into market access.
- ✅Pharma, Life Sciences, and Consulting Professionals transitioning into market access roles.
Programme content
Explore the full market access journey from clinical trial design to early access strategies.
Master evidence generation, pricing research, negotiation, and lifecycle management.
Includes practical workshops like Alzheimer’s Disease case study and real-world applications.
Analyze market access frameworks across key countries including US, EU, China, and more.
Understand regional variations, EU HTA processes, and global pricing strategies.
Features interactive workshops and panel discussions for international comparison.
Delve into AI, real-world evidence, and innovative pricing and funding models.
Focus on vaccine market access, MedTech pathways, and challenges in low-resource settings.
Engage in workshops covering Rotavirus and MedTech, and explore future market access trends.
Employees of these companies participated in the course.
Experience
Theory & practice
International
Market Access Society
Own communication platform for students
Own journal
FAQ
Is this an online market access course?
Yes, 100% online with flexible access
Who can join?
Anyone interested in or working within market access, pricing, or reimbursement in healthcare.
Practical or theoretical?
Practical applications for each main topic.
Multiple examples from the public domain and lecturers experience.
The full development of a Market Access Plan including strategy, gap analysis, activity prioritization.
Each module will contain case study, workshop, quizzes and live panel discussion session.
Where can I find the exact outline of the course modules?
You can find it here
Is the course certified?
Yes, participants receive a certificate of completion.
What is the exact date of the course?
Sign up to the waitlist and we’ll notify you as soon as the course opens for enrollment.
FAQ
Is this an online market access course?
Yes, 100% online with flexible access
Who can join?
Anyone interested in or working within market access, pricing, or reimbursement in healthcare.
Practical or theoretical?
Practical applications for each main topic.
Multiple examples from the public domain and lecturers experience.
The full development of a Market Access Plan including strategy, gap analysis, activity prioritization.
Each module will contain case study, workshop, quizzes and live panel discussion session.
Where can I find the exact outline of the course modules?
You can find it here
Is the course certified?
Yes, participants receive a certificate of completion.
What is the exact date of the course?
Sign up to the waitlist and we’ll notify you as soon as the course opens for enrollment.
FAQ after
What to do if you don't see any email from us in your inbox?
Check your SPAM, Promotions, Notifications, or other email folders – sometimes messages end up there automatically.
Search your mailbox for the word “IMAUD” or MAS.
Make sure you provided the correct email address during registration.
If you still haven’t received any message within 24 hours, please contact us at [support email address] – we’ll help you regain access.
What to do if, after logging in, you don't have access to the IMAUD course (lock icon)?
Make sure you are logging in with the same account used to purchase the course.
Refresh the page or log out and back in again.
If you still don’t see the course, contact us with the email address used for login and include a screenshot of your course dashboard – this will help us resolve the issue faster.
What to do if you don’t know how to navigate the course?
Check the platform tutorial – follow it step by step.
If you still have problems, write to our support team.
Remember: some course content unlocks only after completing previous modules.
discussion session.
Other issues
For technical problems (e.g., page errors, videos not playing), try using a different browser (Google Chrome or Firefox) and clear your cache.
If you have questions about course content, certificates, or deadlines, contact us via:
📧 [contact email address]
or via DM on the Community
Ours instructors
Mondher Toumi
CEO at InovIntell, President of MAS
Frank Ulrich Fricke
Professor of Health Economics at the Nuremberg Institute of Technology
Dávid Dankó
Managing partner at Ideas & Solutions
Elaine Julian
Founder & Managing Director at TRI-connect
Karolina Świerk
Consultant of HEOR at Clever-Access
Natasa Zibelnik
Head of Market Access EMEA - Oncology at Menarini Group
Bertrand Tardivel
General Manager and Founder at Ataraxys
Sibilia Quilici
Executive Director Vaccines Europe at EFPIA
Sandrine Ruiz
Senior Market Access Manager at Immunocore
Michał Pochopień
Co-founder, Co-lead of Modelling Department at Clever-Access
Elżbieta Olewińska
Principal Consultant, Evidence Synthesis at Clever-Access
Aurélie Millier
Senior Principal Consultant PRMA & HEOR Integrated Projects at Clever Access
Tomas Matthews
Senior Director, Global Business Unit Leader at Johnson & Johnson
François Houÿez
Director of Treatment Information and Access at European Organisation for Rare Diseases
Clément François
Partner, HEOR and Market Access at Putnam PHMR
Oleg Borisenko
Director at MTRC
Ekkehard Beck
Senior Director at Moderna
Emilie Clay
Co-founder & Head of HEOR at Clever-Access
Claudio Jommi
Professor of Management at UPO University
Anna Kapuśniak
Senior Consultant PRMA at Clever-Access
Krzysztof Kloc
Co-founder & Vice Head of PRMA at Clever-Access
Mira Pavlovic
Scientific Advisor Clinical, Regulatory & HTA
Samuel Aballéa
Chief Operations Officer at InovIntell
Oriol Solà-Morales
Founder of HITT
Vivian Chen
Professor and Senior Researcher at Tsinghua University-Hospital Management Institute
Philippe Larame
Head of Payer Engagement, Capabilities & Innovation at Ipsen Headquarters
Ulf Person
Senior Advisor at IHE - The Swedish Institute for Health Economics
Keith Tolley
Director at Tolley Health Economics
Ataru Igarashi
Associate Professor at Yokohama City University School of Medicine
James Chambers
associate professor at Tufts Medical Center Institute for Clinical Research and Health Policy Studies
Dávid Danko
managing partner at Ideas & Solutions (I&S)
Kagan Atikeler
Public Affairs and Market Access Lead
Tingting Qiu
Management Team Member at ECONiX
Monica Otto
Director for Executive Education - Government, Health & Non-Profit - SDA Bocconi, Lecturer - Bocconi University Cremona
Mouna Jameleddine
PharmD, MSc, Health Technology Assessment Director-INEAS, Chair of the ISPOR HTA roundtable for Middle East & Africa
Anne d’Andon
Consultant senior (Indépendant)
Oriol Solà-Morales
President Fundació HiTT & CEO at HITT
Antoni Gilabert Perramon
Director of Innovation and Partnership at Catalan Health and Social Care Consortium
Juergen Wasem
Chairperson bei Arbitration Bord Fees for Digital Health Apps in Social Health INsurance, National Level
James Chambers
Associate Professor at Tufts Medical Center
🎓 Get your first free IMAUD lesson
Before the new edition of the IMAUD Online Market Access Course begins in January 2026, we’d love to give you a first look. 🌱
Sign up to get a free lesson from Prof. Mondher Toumi and see how the new IMAUD format feels – lighter, clearer, and closer to real-world Market Access.
No commitments, no pressure.
Just learning that matters.
Sign up and get your free lesson 👉